Independent Research advice for BB Biotech
| Date | Bank | Stock | Advice | Price | Difference |
|---|---|---|---|---|---|
| June 27, 2014 | Independent Research | BB Biotech | Buy | 150.00 CHF | -91.33 % |
Advice details
Frankfurt - Op 27 Jun 2014 herhalen de analisten van Independent Research hun koopadvies voor BB Biotech (ISIN: CH0038389992 / Mnemo: BBZ). Het 12-maands koersdoel wordt opwaarts bijgesteld van 140.0 CHF naar 150.0 CHF.
Back
| About us | Network | Partners |
| Fpgroup.nlinfo@analist.nlRSS feedContactIntellectual Property Photos |
Analist.nlLinksISIN
|
MorningstarPrudena.comAAII.comNASDAQvwd GroupEuronextBATS Chi-x
|
©2025 ValueSpectrum. All Rights Reserved
Developed and maintained by 